Par interest in hi tech pharmacal

Quote

Anonymous

Guest
Wiil par use the new debt and cash balances to buy their partner HITK (asacol et al) ?



Dynamic and growing, Hi-Tech Pharmacal is a specialty pharmaceutical company that develops, manufactures and markets generic and branded prescription and OTC products. We specialize in difficult-to-manufacture liquid and semi-solid dosage forms and offer a wide range of sterile ophthalmic, otic and inhalation products.

The Generic Sales Division forms Hi-Tech's core business. The Company is dedicated to its continued growth and is strengthened through its other sales and marketing divisions:

Health Care Products Division > a leading developer and marketer of branded OTC products for the diabetes, pain and allergy markets.

ECR Pharmaceuticals > markets branded prescription products.

Midlothian Laboratories > focuses on providing niche generic pharmaceutical products to the US market.
 






Par grew up from being acquired to acquiring?


Anonymous said:
Wiil par use the new debt and cash balances to buy their partner HITK (asacol et al) ?



Dynamic and growing, Hi-Tech Pharmacal is a specialty pharmaceutical company that develops, manufactures and markets generic and branded prescription and OTC products. We specialize in difficult-to-manufacture liquid and semi-solid dosage forms and offer a wide range of sterile ophthalmic, otic and inhalation products.

The Generic Sales Division forms Hi-Tech's core business. The Company is dedicated to its continued growth and is strengthened through its other sales and marketing divisions:

Health Care Products Division > a leading developer and marketer of branded OTC products for the diabetes, pain and allergy markets.

ECR Pharmaceuticals > markets branded prescription products.

Midlothian Laboratories > focuses on providing niche generic pharmaceutical products to the US market.
Click to expand...
 
























Anonymous said:
Wiil par use the new debt and cash balances to buy their partner HITK (asacol et al) ?



Dynamic and growing, Hi-Tech Pharmacal is a specialty pharmaceutical company that develops, manufactures and markets generic and branded prescription and OTC products. We specialize in difficult-to-manufacture liquid and semi-solid dosage forms and offer a wide range of sterile ophthalmic, otic and inhalation products.

The Generic Sales Division forms Hi-Tech's core business. The Company is dedicated to its continued growth and is strengthened through its other sales and marketing divisions:

Health Care Products Division > a leading developer and marketer of branded OTC products for the diabetes, pain and allergy markets.

ECR Pharmaceuticals > markets branded prescription products.

Midlothian Laboratories > focuses on providing niche generic pharmaceutical products to the US market.
Click to expand...

HITK has over $$1b in compounds pending with the fda so that is quite an incentive
 


















Anonymous said:
Wiil par use the new debt and cash balances to buy their partner HITK (asacol et al) ?



Dynamic and growing, Hi-Tech Pharmacal is a specialty pharmaceutical company that develops, manufactures and markets generic and branded prescription and OTC products. We specialize in difficult-to-manufacture liquid and semi-solid dosage forms and offer a wide range of sterile ophthalmic, otic and inhalation products.

The Generic Sales Division forms Hi-Tech's core business. The Company is dedicated to its continued growth and is strengthened through its other sales and marketing divisions:

Health Care Products Division > a leading developer and marketer of branded OTC products for the diabetes, pain and allergy markets.

ECR Pharmaceuticals > markets branded prescription products.

Midlothian Laboratories > focuses on providing niche generic pharmaceutical products to the US market.
Click to expand...

you gotta believe
 






Anonymous said:
Wiil par use the new debt and cash balances to buy their partner HITK (asacol et al) ?



Dynamic and growing, Hi-Tech Pharmacal is a specialty pharmaceutical company that develops, manufactures and markets generic and branded prescription and OTC products. We specialize in difficult-to-manufacture liquid and semi-solid dosage forms and offer a wide range of sterile ophthalmic, otic and inhalation products.

The Generic Sales Division forms Hi-Tech's core business. The Company is dedicated to its continued growth and is strengthened through its other sales and marketing divisions:

Health Care Products Division > a leading developer and marketer of branded OTC products for the diabetes, pain and allergy markets.

ECR Pharmaceuticals > markets branded prescription products.

Midlothian Laboratories > focuses on providing niche generic pharmaceutical products to the US market.
Click to expand...





some rumors have legs and happen
 
















































Anonymous said:
Wiil par use the new debt and cash balances to buy their partner HITK (asacol et al) ?



Dynamic and growing, Hi-Tech Pharmacal is a specialty pharmaceutical company that develops, manufactures and markets generic and branded prescription and OTC products. We specialize in difficult-to-manufacture liquid and semi-solid dosage forms and offer a wide range of sterile ophthalmic, otic and inhalation products.

The Generic Sales Division forms Hi-Tech's core business. The Company is dedicated to its continued growth and is strengthened through its other sales and marketing divisions:

Health Care Products Division > a leading developer and marketer of branded OTC products for the diabetes, pain and allergy markets.

ECR Pharmaceuticals > markets branded prescription products.

Midlothian Laboratories > focuses on providing niche generic pharmaceutical products to the US market.
Click to expand...

Why par does not put that $300m to use and buy into generics like hi tech pharma is beyond me?
 


















Top Bottom
Back
Quote